Evaxion A (EVAX) Net Cash Flow (2020 - 2022)
Evaxion A's (EVAX) quarterly Net Cash Flow came in at -$5.6 million in Q2 2022, down 143.25% YoY from $12.9 million in Q2 2021, and down 817.13% on a QoQ basis from -$607000.0 in Q1 2022.
Evaxion A (EVAX) Net Cash Flow (2020 - 2022) Analysis & Trends
Evaxion A (EVAX) has 3 years of Net Cash Flow data on file, last reported at -$5.6 million in Q2 2022.
- Quarterly Net Cash Flow fell 143.25% year-over-year to -$5.6 million in Q2 2022, while the trailing twelve-month figure through Mar 2023 was -$5.6 million (down 130.18% YoY) and the FY2025 annual result came in at $13.9 million, up 116325.0% from the prior year.
- Net Cash Flow fell to -$5.6 million in Q2 2022, from -$607000.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $20.9 million in Q1 2021 to a low of -$5.6 million in Q2 2022.
- A 3-year average of $2.9 million and a median of -$1.2 million in 2020 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2021 — Net Cash Flow jumped 785.14% — and 2022, when it slumped 143.25%.
- Tracing EVAX's Net Cash Flow over 3 years: stood at -$1.7 million in 2020, then jumped by 462.31% to $6.2 million in 2021, then slumped by 190.07% to -$5.6 million in 2022.
- The last three Net Cash Flow figures came in at -$5.6 million (Q2 2022), -$607000.0 (Q1 2022), and $6.2 million (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Evaxion A | 27.61 Mn | 27.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -5.57 Mn |
| Jun 30, 2022 | -5.57 Mn |
| Mar 31, 2022 | -607,000.00 |
| Mar 31, 2022 | -607,000.00 |
| Sep 30, 2021 | 6.18 Mn |
| Sep 30, 2021 | 6.18 Mn |
| Jun 30, 2021 | 12.87 Mn |
| Jun 30, 2021 | 12.87 Mn |
| Mar 31, 2021 | 20.89 Mn |
| Mar 31, 2021 | 20.89 Mn |
| Sep 30, 2020 | -1.71 Mn |
| Sep 30, 2020 | -1.71 Mn |
| Jun 30, 2020 | -5.42 Mn |
| Jun 30, 2020 | -5.42 Mn |
| Mar 31, 2020 | -3.05 Mn |
| Mar 31, 2020 | -3.05 Mn |